Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros










Intervalo de ano de publicação
3.
An. med. interna (Madr., 1983) ; 23(12): 565-568, dic. 2006. tab
Artigo em Es | IBECS | ID: ibc-051768

RESUMO

Objetivo: Conocer el número de pacientes que ingresan o que desarrollan durante su ingreso en un hospital ETEV, analizar el manejo de esta enfermedad y sentar las bases para un estudio prospectivo de dicha enfermedad. Métodos: Se trata de un estudio descriptivo retrospectivo de pacientes diagnosticados de ETEV durante su ingreso en el Hospital Clínico San Carlos de Madrid en un período de 6 meses. Se recogen los datos relacionados con antecedentes epidemiológicos, diagnóstico, tratamiento y complicaciones de los pacientes con trombosis venosa profunda (TVP), tromboembolismo pulmonar (TEP) o ambas (TVP + TEP). Resultados: Del 1 de octubre de 2003 al 31 de marzo de 2004, 239 pacientes fueron diagnosticados de ETEV (64 TVP, 125 TEP y 51 TVP + TEP) al alta en nuestro hospital con una edad media de 73,2 años (desviación estándar 13,64). Como factores de riesgo con diferencias estadísticamente significativas detectamos la quimioterapia, el infarto agudo de miocardio y la obesidad. No se ha observado relación entre el tipo de tratamiento utilizado y la aparición de hemorragia. Los pacientes con episodios previos de ETEV presentaron hemorragias más frecuentemente que aquellos sin dichos antecedentes. La hipocinesia de ventrículo derecho en el ecocardiograma fue un factor de mal pronóstico para la muerte por ETEV así como la aparición de TVP + TEP. Conclusión: En más del 50% de los pacientes la ETEV era TEP y más del 60% eran mujeres. Es importante disponer de información sobre estos pacientes, ya que 2/3 ingresan en medicina interna. La quimioterapia, el IAM y la obesidad fueron factores que se asociaron a TVP, TEP y TVP + TEP de forma significativa, respectivamente. La hipocinesia de ventrículo derecho en el ecocardiograma fue un factor de mal pronóstico para la muerte por ETEV así como la coincidencia de TVP + TEP


Aim: To know the number of patients that are admitted in the hospital with TED or those who have developed it during their stay, analyzing how to manage this disease and make a basis for a prospective study of this disease. Methods: It is a descriptive and retrospective study of TED diagnosed patients during their stay at the Hospital Clínico San Carlos of Madrid for a 6 month period. Data related with epidemiologic records, diagnosis, treatment and complications of patients with Deep-Vein Thrombosis (DVT), Pulmonary Thromboembolism (PTE) or both (DVT+PTE) are collected. Results: From October 1st of 2003 to March 31st of 2004, 239 patients were diagnosed with TED (64 DVT, 125 PTE y 51 DVT + PTE) when they were discharged from our hospital, with an average age of 73.2 years (standar desviation 13.64). We classify as risky factors with significative statistical diferences chemotherapy, acute myocardium infarction and obesity. It has not been found any relation between the treatment used and the development of hemorrage. Patients with previous episodies of TED had more frequent hemorragies than those without such records. Hypokinesia in the right ventricle shown on the echocardiogram supposed a gloomy prognosis of the death for TED as well as the development of DVT + PTE. Conlusion: In more than a 50% of patients, TED was PTE and more than a 60% were women. It is important to obtain information about these patients because 2/3 of them are admitted to internal medicine. Chemotherapy, AIM and obesity were factors significatively associated to DVT, PTE and DVT + PTE. Hypokinesia in the right ventricle shown on the echocardiogram supposed a gloomy prognosis for TED as well as the development of DVT + PTE


Assuntos
Masculino , Feminino , Pessoa de Meia-Idade , Humanos , Trombose Venosa/complicações , Trombose Venosa/diagnóstico , Trombose Venosa/terapia , Embolia Pulmonar/diagnóstico , Fatores de Risco , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Mortalidade Hospitalar , Anticoagulantes/uso terapêutico , Diagnóstico Diferencial , Estudos Retrospectivos , Embolia Pulmonar/complicações , Trombose Venosa/epidemiologia , Anticoagulantes/administração & dosagem , Anticoagulantes/farmacocinética
4.
An Med Interna ; 23(12): 565-8, 2006 Dec.
Artigo em Espanhol | MEDLINE | ID: mdl-17371142

RESUMO

AIM: To know the number of patients that are admitted in the hospital with TED or those who have developed it during their stay, analyzing how to manage this disease and make a basis for a prospective study of this disease. METHODS: It is a descriptive and retrospective study of TED diagnosed patients during their stay at the Hospital Clínico San Carlos of Madrid for a 6 month period. Data related with epidemiologic records, diagnosis, treatment and complications of patients with Deep-Vein Thrombosis (DVT), Pulmonary Thromboembolism (PTE) or both (DVT+PTE) are collected. RESULTS: From October 1st of 2003 to March 31st of 2004, 239 patients were diagnosed with TED (64 DVT, 125 PTE y 51 DVT + PTE) when they were discharged from our hospital, with an average age of 73.2 years (standard desviation 13.64). We classify as risky factors with significative statistical differences chemotherapy, acute myocardium infarction and obesity. It has not been found any relation between the treatment used and the development of hemorrhage. Patients with previous episodes of TED had more frequent hemorrhagies than those without such records. Hypokinesia in the right ventricle shown on the echocardiogram supposed a gloomy prognosis of the death for TED as well as the development of DVT + PTE. CONCLUSION: In more than a 50% of patients, TED was PTE and more than a 60% were women. It is important to obtain information about these patients because 2/3 of them are admitted to internal medicine. Chemotherapy, AIM and obesity were factors significatively associated to DVT, PTE and DVT + PTE. Hypokinesia in the right ventricle shown on the echocardiogram supposed a gloomy prognosis for TED as well as the development of DVT + PTE.


Assuntos
Embolia Pulmonar/epidemiologia , Trombose Venosa/epidemiologia , Idoso , Feminino , Humanos , Masculino , Estudos Retrospectivos
7.
An Med Interna ; 20(5): 247-50, 2003 May.
Artigo em Espanhol | MEDLINE | ID: mdl-12831299

RESUMO

Kikuchi-Fujimoto disease, also known as hystiocytic necrotizing lymphadenitis, is an unusual entity which affects predominantely young Asiatic females, although its distribution is world-wide. Cardinal symptoms are fever and adenopathy, generally cervical, although generalized and extraganglionar cases have been described. Considered a self-limiting disease, it has to be differentiated by pathologic analysis from other less-benign disorders such as lymphoma or histiocytoma, which bear worse prognosis and may require specific treatment. Although the origin of this disease is unknown, a viral origin is postulated and the immune system is involved Kikuchi disease has been associated to other entities such as subcutaneous lupus erythematosus, Hashimoto thyroiditis, etc... requiring that patients be followed immunologically alter diagnosis of this disease. We present a case of Kikuchi disease associated with subacute lymphocytic thyroiditis.


Assuntos
Linfadenite Histiocítica Necrosante/diagnóstico , Adulto , Autoanticorpos/sangue , Doenças Autoimunes/complicações , Doenças Autoimunes/imunologia , Diagnóstico Diferencial , Feminino , Linfadenite Histiocítica Necrosante/complicações , Linfadenite Histiocítica Necrosante/imunologia , Linfadenite Histiocítica Necrosante/patologia , Humanos , Tireoidite Autoimune/complicações , Tireoidite Autoimune/imunologia
8.
An. med. interna (Madr., 1983) ; 20(5): 247-250, mayo 2003.
Artigo em Es | IBECS | ID: ibc-23674

RESUMO

La enfermedad de Kikuchi-Fujimoto, también conocida como linfadenitis necrotizante histiocitaria no linfocítica, es una entidad clínica poco frecuente que afecta principalmente a mujeres jóvenes de procedencia asiática, aunque tiene una distribución universal. Es característica la aparición de fiebre y adenopatías, habitualmente localizadas a nivel cervical, aunque hay casos descritos de afectación generalizada o extraganglionar. Su interés estriba en que, aun siendo un proceso benigno y autolimitado, es necesario un diagnóstico anatomo-patológico de exclusión de otras entidades clínicas de peor pronóstico que precisan tratamiento más específico (linfoma, histiocitoma...).A pesar de que su etiopatogenia es desconocida, se postula un origen vírico y una mediación inmunológica en el desarrollo de la enfermedad. Se ha descrito asociación de la enfermedad de Kikuchi con procesos como el lupus eritematoso subcutáneo, tiroiditis/ Hashimoto, lo que obliga a un posterior seguimiento inmunológico de la enfermedad tras su diagnóstico, ante la posibilidad de aparición con el tiempo de un proceso autoinmune. Se presenta el caso de una enfermedad de Kikuchi asociada a tiroiditis subaguda linfocitaria (AU)


No disponible


Assuntos
Adulto , Feminino , Humanos , Tireoidite Autoimune , Linfadenite Histiocítica Necrosante , Autoanticorpos , Doenças Autoimunes , Diagnóstico Diferencial
11.
Med Clin (Barc) ; 72(10): 410-3, 1979 May 25.
Artigo em Espanhol | MEDLINE | ID: mdl-470488

RESUMO

The level of urinary excretion of hydroxyproline is considered as an index of the metabolic activity of the collagen. It increases in situations which include an increase in the osteoblastic activity or in the bone resorption. In respiratory insufficiency a series of conditions occur which are theoretically capable of modyfing this parameter. Twelve patients (9 males and 3 women) with chronic respiratory disease in a situation of respiratory insufficiency (hypoxemia and/or hypercapnia at rest) were studied. The urinary excretion of hydroxyproline in these patients was 15.30 +/- 8.16 mg/day/m2, significantly greater than that of a control group with similar characteristics which was 9.97 +/- 3.07 mg/day/m2 (p less than 0.05; Student's t test). The existence of a significant correlation between the urinary excretion of hydroxyproline and the degree of hypoxemia (r = 0.66; p less than 0.01) was likewise verified; in the same way, although to a lesser degree with the hypercapnia (r = 0.62; p less than 0.05). The different factors capable of influencing the bone metabolism in respiratory insufficiency are discussed, as well as the effects of the medications used by these patients. It is possible, on the other hand, that the increase of the urinary excretion of hydroxyproline does not depend only on alterations in the metabolic condition of the bone, but also on a reduction in the hepatic metabolism of the amino acid in relation with gasometric modifications.


Assuntos
Hidroxiprolina/urina , Hipercapnia/urina , Hipóxia/urina , Insuficiência Respiratória/urina , Idoso , Osso e Ossos/metabolismo , Doença Crônica , Colágeno/metabolismo , Feminino , Humanos , Hipercapnia/metabolismo , Hipóxia/metabolismo , Masculino , Pessoa de Meia-Idade , Valores de Referência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...